RANI news

Latest 2 stories · newest Jun 29, 2026

RANI

Rani Therapeutics enters into employment agreement for Nicholas M. Maestas

Rani Therapeutics LLC has issued an offer letter to Nicholas M. Maestas to serve as its new Chief Financial Officer, effective June 29, 2026. The hiring of a new CFO marks a significant leadership transition for the biotechnology company, potentially influencing its financial oversight and strategic…

Leadership Jun 29, 2026 sentiment +0.20 SEC filing ↗

RANI

Rani Therapeutics issues pre-funded common stock purchase warrants dated May 27, 2026

Rani Therapeutics Holdings filed warrant documentation allowing holders to purchase Class A Common Stock at a specified exercise price starting from the original issue date. The offering provides investors with equity participation rights in the biopharmaceutical company.

Offering May 27, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same RANI feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/RANI/newsSTART FREE